BioTech
New sickle cell disease CRISPR treatments can’t make up for the shortage of adult hematologists
After decades of limited progress in the treatment of sickle cell disease (SCD), both patients and physicians are on the verge of monumental change. On
Robert Brodsky
December 12, 2023